Topical Vitamin C for Treatment of Basal Cell Cancer
Status:
Completed
Trial end date:
2019-06-01
Target enrollment:
Participant gender:
Summary
Randomized coomparative trial of a 30% solution of ascorbic acid in 95% dimethylsulfoxide
applied topically twice a day for 8 weeks vs 5% imiquimod cream in the treatment biopsy
proven basal cell carcinomas inotherwise healthy adult patients. Outcome measure was biopsy
proven resolution of the carcinoma.